Understanding the crosstalk between spatially separated RNP granules during cellular stress responses

Lead Research Organisation: University of Sheffield
Department Name: Neurosciences

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

Phase separation is emerging as a key regulatory principle in eukaryotes, with the assembly and dissolution of membraneless organelles allowing the switch-like regulation of their RNA and protein components activities. Our overarching aim is to understand how RNP granules shape the cellular response to adverse conditions, uncovering how they specialise during stress to exert a specific response and mechanisms of their crosstalk under conditions of spatial segregation.
Given their role in healthy responses and their deregulation in diseases such as viral infections and neurodegeneration, we will use stress granules and paraspeckles as prototypical RNP granules for cytoplasmic and nuclear membraneless organelles. First, we will determine how different stresses trigger the assembly of heterogeneous stress granules and paraspeckles with distinct functional flavours by establishing their structure, dynamics and composition. We will use high-throughput imaging and biochemical isolation of RNP granules coupled to proteomics to define the stress-specific properties of these RNP granules. Next and building on our recent evidence that stress granules can regulate paraspeckles assembly, we will identify the mechanisms responsible for this crosstalk by characterising the signalling pathways and specific proteins involved using both screening and targeted approaches informed by the proteomics. Finally, we will reveal how the assembly of aberrant stress granules impacts on paraspeckles and cellular functions in neurons using models of neurodegenerative diseases; and how the crosstalk between stress granules and paraspeckles contributes to antiviral signalling in infected cells, using viruses known to induce stress granules.
Our study will establish guiding principles for how membraneless organelles specialise and communicate in healthy and pathological conditions, uncovering novel rules of cellular adaptation during stress.
 
Description NEAT1 isoforms in the regulation of cellular glucose metabolism downstream TDP-43 dysfunction in ALS
Amount £114,917 (GBP)
Organisation Motor Neurone Disease Association (MND) 
Sector Charity/Non Profit
Country United Kingdom
Start 10/2023 
End 03/2027
 
Title A suite of tools for the identification of small molecule modulators of NEAT1_2/paraspeckles 
Description Nuclear Paraspeckle Assembly Transcript 1 (NEAT1) is a long non-coding RNA (lncRNA) with a plethora of physiological and pathological roles. The longer NEAT1 isoform, NEAT1_2, assembles a ribonucleoprotein granule, the paraspeckle. NEAT1_2/paraspeckle dysregulation has been linked to multiple human diseases making it an attractive target for therapy development. However currently the discovery of chemical modulators of NEAT1_2/paraspeckles is hindered by the lack of appropriate tools. To fill this gap, we developed and validated a toolkit comprised of biochemical and cell-based assays for the identification of small molecule NEAT1_2 binders. The NEAT1_2 triple helix stability element was utilised as the target in the biochemical assays, and the cellular assay ('ParaQuant') was based on high-content imaging of NEAT1_2 in fixed cells. As a proof of principle, these assays were used to screen a 1,200-compound FDA-approved drug library and a 170-compound kinase inhibitor library and to confirm the screening hits. The assays are simple to establish, use only commercially-available reagents and are scalable for higher throughput. In particular, ParaQuant is a cost-efficient assay suitable for any cells growing in adherent culture, including motor neurons, and amenable to multiplexing. 
Type Of Material Technology assay or reagent 
Year Produced 2022 
Provided To Others? Yes  
Impact Novel tools to guide the search, validation and optimisation of NEAT1_2/paraspeckle-targeted small molecules were developed - methods paper was published in Nucleic Acids Research journal. 
URL https://pubmed.ncbi.nlm.nih.gov/36099417/
 
Description Characterisation of novel nuclear bodies involved in FUS protein autoregulation 
Organisation King's College London
Country United Kingdom 
Sector Academic/University 
PI Contribution I have discovered formation of a novel nuclear body by FUS transcripts and now aim to characterise its composition, function and role in FUS autoregulation (including the impact of ALS mutations).
Collaborator Contribution Prof Eugene Makeyev's team developed a novel method for analysis of RNP granule composition by proximity labeling; this method will be applied to characterise the composition of these nuclear bodies.
Impact N/A
Start Year 2022
 
Description Developing new tools for differential analysis of NEAT1 isoforms in live cells 
Organisation Cardiff University
Country United Kingdom 
Sector Academic/University 
PI Contribution In collaboration with teams at the Medicines Discovery Institute, we are developing cell-based platforms to monitor NEAT1 expression in live cells using bioluminescent and fluorescent reporters. My team is developing new reporter cell lines, to be used for the screening and validation of new small molecules with the Institute.
Collaborator Contribution Cell biology and chemistry teams of the Medicines Discovery Institute will provide their expertise in assay validation, small molecule screening and drug development to establish and refine new cell based assays and identify chemicals to differentially target NEAT1 isoforms. These molecules will be subsequently used as templates for the development of NEAT1-targeting therapeutics, including with the Institute.
Impact Respective cell lines developed (MS2 system, aptamer Mango system) and characterised and used in ongoing experiments. In addition, an approach (assay) to monitor NEAT1_2/paraspeckles in fixed non-modified cells based on in situ hybridisation was developed and successfully used for a pilot screen that allowed to identify a novel cellular pathways regulating paraspeckles.
Start Year 2018
 
Description Dysregulation of NEAT1/paraspeckles in prostate cancer 
Organisation University of Sheffield
Department Sheffield Medical School
Country United Kingdom 
Sector Academic/University 
PI Contribution This collaborative project is with Dr Ning and Dr Richards, the translational oncology group at TUoS. I will contribute my expertise in paraspeckle research and the novel cellular assay that will be used for paraspeckle quantification.
Collaborator Contribution The group is in possession of multiple prostate cancer cell lines, both human and from mouse models. A MSc student is working to characterise NEAT1/paraspeckle abundance in these cell lines and correlate it with the markers of cancer progression, e.g. Hif1alpha pathway activation and metastasis potential.
Impact N/A
Start Year 2022
 
Description RNA tracking in live cells using novel chemical probes 
Organisation Ohio State University
Country United States 
Sector Academic/University 
PI Contribution The collaboration is with Prof Dennis Bong whose team is providing non-commercial fluorescent chemical probes for labeling RNA (NEAT1 and C9ORF72) in living cells. These probes are highly complementary to the proposal aims and will allow efficient characterisation of small molecules from project screens in cellular systems. We are providing molecular cloning (plasmid generation) and cell biology expertise within this project.
Collaborator Contribution The collaboration is with Prof Dennis Bong whose team is providing non-commercial fluorescent chemical probes for labeling RNA (NEAT1 and C9ORF72) in living cells. These probes are highly complementary to the proposal aims and will allow efficient characterisation of small molecules from project screens in cellular systems. We are providing molecular cloning (plasmid generation) and cell biology expertise within this project.
Impact None yet, in progress
Start Year 2022